Study design
This single-blinded, randomized controlled trial involved two parallel groups and was registered on ClinicalTrials.gov in October 2017 (clinical identifier: NCT03318289). The Human Research Ethics Committee of the University of Hong Kong approved the study (approval number: EA1602061). Written informed consent was obtained from each participant prior to data collection. All procedures were conducted in accordance with the Declaration of Helsinki.